Human CD4+ T cells recognize an epitope within α-fetoprotein sequence and develop into TGF-β-producing CD4 + T cells

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 5109-5117

  Alisa, Akeel ^a   Boswell, Sandra ^a   Pathan, Ansar A ^b   Ayaru, Lakshmana ^a   Williams, Roger ^a   Behboudi, Shahriar ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PEPTIDE FRAGMENT;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SURVIVAL RATE; TH1 CELL; TH17 CELL; TH2 CELL; AMINO ACID SEQUENCE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; IMMUNOLOGY; METABOLISM; PHENOTYPE; SENSITIVITY AND SPECIFICITY;

ALPHA-FETOPROTEINS; AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CARCINOMA, HEPATOCELLULAR; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EPITOPES; FORKHEAD TRANSCRIPTION FACTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; PEPTIDE FRAGMENTS; PHENOTYPE; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA;

EID: 44449143517     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.5109     Document Type: Article

References (35)

1. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
2. Beyer, M., and J. L. Schultze. 2006. Regulatory T cells in cancer. Blood 108: 804-811.
3. + T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc. Natl. Acad. Sci. USA 100: 10902-10906.
4. Franco, A., and S. Albani. 2006. Translating the concept of suppressor/regulatory T cells to clinical applications. Int. Rev. Immunol. 25: 27-47.
5. Murgita, R. A., E. A. Goidl, S. Kontianen, and H. Wigzell. 1977. a-Fetoprotein induces suppressor T cells in vitro. Nature 267: 257-259.
6. Um, S. H., C. Mulhall, A. Alisa, A. R. Ives, J. Karani, R. Williams, A. Bertoletti, and S. Behboudi. 2004. a-Fetoprotein impairs APC function and induces their apoptosis. J. Immunol. 173: 1772-1778.
7. Butterfield, L. H. 2004. Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 127: S232-S241.
8. + T-cell responses to a novel a-fetoprotein- derived epitope in hepatocellular carcinoma patients. Clin. Cancer Res. 11:6686 -6694.
9. + T cell responses in hepatocellular carcinoma patients undergoing embolization. J. Immunol. 178: 1914-1922.
10. Liu, Y., S. Daley, V. N. Evdokimova, D. D. Zdobinski, D. M. Potter, and L. H. Butterfield. 2006. Hierarchy of a-fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer. J. Immunol. 177:712-721.
11. Wang, H. Y., D. A. Lee, G. Peng, Z. Guo, Y. Li, Y. Kiniwa, E. M. Shevach, and R. F. Wang. 2004. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20: 107-118.
12. Gehring, A. J., D. Sun, P. T. Kennedy, E. Nolte-'t Hoen, S. G. Lim, S. Wasser, C. Selden, M. K. Maini, D. M. Davis, M. Nassal, and A. Bertoletti. 2007. The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J. Virol. 81: 2940 -2949.
13. Sartoris, S., M. T. Valle, A. L. Barbaro, G. Tosi, T. Cestari, A. D'Agostino, A. M. Megiovanni, F. Manca, and R. S. Accolla. 1998. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity. J. Immunol. 161: 814-820.
14. + regulatory T cells from human peripheral blood. J. Immunol. 166: 7282-7289.
15. Shevach, E. M. 2006. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25: 195-201.
16. Aluvihare, V. R., and A. G. Betz. 2006. The role of regulatory T cells in alloan- tigen tolerance. Immunol. Rev. 212: 330 -343.
17. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
18. Piccirillo, C. A., J. J. Letterio, A. M. Thornton, R. S. McHugh, M. Mamura, H. Mizuhara, and E. M. Shevach. 2002. CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor (1 production and responsiveness. J. Exp. Med. 196: 237-246.
19. + regulatory T cells is mediated by cell surface- bound transforming growth factor β. J. Exp. Med. 194: 629-644.
20. Wahl, S. M., J. Wen, and N. Moutsopoulos. 2006. TGF-β: a mobile purveyor of immune privilege. Immunol. Rev. 213: 213-227.
21. Ali, M. Y., C. F. Grimm, M. Ritter, L. Mohr, H. P. Allgaier, R. Weth, W. O. Bocher, K. Endrulat, H. E. Blum, and M. Geissler. 2005. Activation of dendritic cells by local ablation of hepatocellular carcinoma. J. Hepatol. 43:817-822.
22. Huffman, J. A., W. M. Hull, G. Dranoff, R. C. Mulligan, and J. A. Whitsett. 1996. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J. Clin. Invest. 97: 649-655.
23. Gillessen, S., N. Mach, C. Small, M. Mihm, and G. Dranoff. 2001. Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood 97: 922-928.
24. Sotomayor, E. M., Y. X. Fu, M. Lopez-Cepero, L. Herbert, J. J. Jimenez, C. Albarracin, and D. M. Lopez. 1991. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma: II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-mac- rophage colony-stimulating factor. J. Immunol. 147: 2816 -2823.
25. + T cells and suppresses experimental autoimmune thyroid- itis. J. Immunol. 170: 5511-5522.
26. + regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thy- roiditis. J. Immunol. 174: 7006 -7013.
27. + regulatory T cells. J. Immunol. 177: 5296-5306.
28. Rabinovich, G. A., D. Gabrilovich, and E. M. Sotomayor. 2007. Immunosup- pressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25:267-296.
29. + T cells. J. Clin. Invest. 116: 2777-2790.
30. Jinushi, M., Y. Nakazaki, M. Dougan, D. R. Carrasco, M. Mihm, and G. Dranoff. 2007. MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF. J. Clin. Invest. 117: 1902-1913.
31. Murgita, R. A., and T. B. Tomasi, Jr. 1975. Suppression of the immune response by a-fetoprotein on the primary and secondary antibody response. J. Exp. Med. 141: 269 -286.
32. Murgita, R. A. 1976. The immunosuppressive role of α-fetoprotein during pregnancy. Scand. J. Immunol. 5: 1003-1014.
33. Murgita, R. A., D. C. Hooper, M. Stegagno, T. L. Delovitch, and H. Wigzell. 1981. Characterization of murine newborn inhibitory T lymphocytes: functional and phenotypic comparison with an adult T cell subset activated in vitro by a-fetoprotein. Eur. J. Immunol. 11: 957-964.
34. Matoba, K., N. Iizuka, T. Gondo, T. Ishihara, H. Yamada-Okabe, T. Tamesa, N. Takemoto, K. Hashimoto, K. Sakamoto, T. Miyamoto, et al. 2005. Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma. Int. J. Cancer 115: 231-240.
35. Fu, J., D. Xu, Z. Liu, M. Shi, P. Zhao, B. Fu, Z. Zhang, H. Yang, H. Zhang, C. Zhou, et al. 2007. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132: 2328 -2339.